X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (79) 79
male (71) 71
female (69) 69
middle aged (66) 66
hematology (65) 65
index medicus (61) 61
adult (58) 58
aged (56) 56
life sciences (40) 40
oncology (37) 37
aged, 80 and over (33) 33
adolescent (28) 28
prognosis (26) 26
treatment outcome (26) 26
cancer (25) 25
disease (24) 24
antineoplastic combined chemotherapy protocols - therapeutic use (21) 21
chemotherapy (21) 21
survival (19) 19
disease-free survival (18) 18
retrospective studies (18) 18
young adult (18) 18
survival analysis (17) 17
therapy (17) 17
myelodysplastic syndromes (15) 15
myelodysplastic syndromes - drug therapy (14) 14
survival rate (14) 14
myelodysplastic syndromes - genetics (13) 13
recurrence (13) 13
abridged index medicus (12) 12
classification (12) 12
care and treatment (11) 11
follow-up studies (11) 11
hodgkin disease - drug therapy (11) 11
hodgkin disease - pathology (11) 11
hodgkin lymphoma (11) 11
myelodysplastic syndromes - mortality (11) 11
neoplasm staging (11) 11
remission induction (11) 11
risk factors (11) 11
[ sdv.can ] life sciences [q-bio]/cancer (10) 10
[sdv.can]life sciences [q-bio]/cancer (10) 10
hodgkin disease - therapy (10) 10
hodgkin's disease (10) 10
lymphomas (10) 10
mutation (10) 10
cohort studies (9) 9
combined modality therapy (9) 9
hemic and lymphatic diseases (9) 9
human health and pathology (9) 9
karyotyping (9) 9
leukemia (9) 9
lymphoma (9) 9
patients (9) 9
response criteria (9) 9
acute myeloid-leukemia (8) 8
analysis (8) 8
antineoplastic combined chemotherapy protocols - administration & dosage (8) 8
hematology, oncology and palliative medicine (8) 8
hodgkin disease - mortality (8) 8
relapse (8) 8
risk (8) 8
trial (8) 8
vinblastine (8) 8
anemia (7) 7
azacitidine - therapeutic use (7) 7
chromosome aberrations (7) 7
disease progression (7) 7
myelodysplastic syndrome (7) 7
phase-ii (7) 7
stem-cell transplantation (7) 7
transplantation (7) 7
acute myeloid leukemia (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
bleomycin (6) 6
bone-marrow transplantation (6) 6
chromosome deletion (6) 6
colony-stimulating factor (6) 6
combination chemotherapy (6) 6
cytarabine - administration & dosage (6) 6
doxorubicin (6) 6
leukemia, myeloid, acute - drug therapy (6) 6
mds (6) 6
prednisone - administration & dosage (6) 6
prognostic-factors (6) 6
radiation (6) 6
radiotherapy (6) 6
salvage therapy (6) 6
scoring system (6) 6
stem cell transplantation (6) 6
toxicity (6) 6
abvd (5) 5
antimetabolites, antineoplastic - therapeutic use (5) 5
article (5) 5
bleomycin - administration & dosage (5) 5
cooperative group (5) 5
cytogenetics (5) 5
diagnosis (5) 5
doxorubicin - administration & dosage (5) 5
elderly (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Hematology, ISSN 0361-8609, 04/2014, Volume 89, Issue 4, pp. 410 - 416
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2017, Volume 12, Issue 3, pp. e0172147 - e0172147
The risk and clinical significance of cardiac iron overload due to chronic transfusion varies with the underlying disease. Cardiac iron overload shortens the... 
MORTALITY | SURVIVAL | RESONANCE | MORBIDITY | CHELATION-THERAPY | DEPENDENT PATIENTS | MULTIDISCIPLINARY SCIENCES | DISEASE | ACCUMULATION | BETA-THALASSEMIA | CHILDREN | Heart - physiopathology | Thalassemia - blood | Myelodysplastic Syndromes - physiopathology | Anemia, Sickle Cell - physiopathology | Humans | Middle Aged | Male | Myelodysplastic Syndromes - blood | Iron Overload - physiopathology | Iron Overload - blood | Blood Transfusion | Iron Chelating Agents | Myocardium - metabolism | Adolescent | Adult | Female | Anemia, Sickle Cell - blood | Thalassemia - physiopathology | Child | Iron - blood | Sickle cell anemia | Cardiac patients | Analysis | Thalassemia | Iron | Research | Health aspects | Myelodysplastic syndromes | Blood transfusions | Heart | Erythropoiesis | Pediatrics | Transferrin | Nuclear magnetic resonance--NMR | Transfusion | Laboratories | Liver | Ferritin | Disorders | Macrophages | Blood | Myelodysplastic syndrome | Red blood cells | Chelation | Hemoglobin | Sickle cell disease | Heart diseases | Age | Life expectancy | Hematology | Anemia | Research & development--R&D | Magnetic resonance | Inflammation | Patients | Coronary artery disease | Chromatography | Hospitals | Life span | Scientific imaging | Hepcidin | Mass spectrometry | Index Medicus | Life Sciences | Human health and pathology | Research & development | Nuclear magnetic resonance | R&D | NMR
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2017, Volume 35, Issue 16, pp. 1786 - 1794
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 12, pp. 1188 - 1194
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 04/2009, Volume 115, Issue 8, pp. 1680 - 1691
BACKGROUND: The objective of this study was to analyze cause‐specific excess mortality in adult patients with Hodgkin lymphoma (HL) with respect to treatment... 
relative survival | causes of death | Hodgkin lymphoma | long‐term survival | Long-term survival | Causes of death | Relative survival | Prognosis | Toxicity | Mortality | Radiation | Population studies | Regression analysis | Radiotherapy | Survival | Infection | Chemotherapy | Models | Cardiovascular diseases | Age | Hodgkin's disease | Cancer | Life Sciences
Journal Article